Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

KNTE | Kinnate Biopharma Inc

Index- P/E- EPS (ttm)-2.82 Insider Own57.98% Shs Outstand44.34M Perf Week0.00%
Market Cap65.93M Forward P/E- EPS next Y-1.15 Insider Trans51.59% Shs Float19.79M Perf Month-39.13%
Income-127.16M PEG- EPS next Q-0.66 Inst Own27.58% Short Float / Ratio4.73% / 4.64 Perf Quarter-53.80%
Sales0.00M P/S- EPS this Y7.90% Inst Trans0.95% Short Interest0.94M Perf Half Y-77.09%
Book/sh4.20 P/B0.33 EPS next Y52.51% ROA-47.09% Target Price27.71 Perf Year-88.98%
Cash/sh3.92 P/C0.36 EPS next 5Y- ROE-53.95% 52W Range1.32 - 12.65 Perf YTD-77.05%
Dividend- P/FCF- EPS past 5Y-96.74% ROI-63.46% 52W High-88.93% Beta0.26
Dividend %- Quick Ratio11.96 Sales past 5Y0.00% Gross Margin- 52W Low6.14% ATR0.17
Employees84 Current Ratio11.96 Sales Q/Q- Oper. Margin0.00% RSI (14)28.82 Volatility9.98% 9.79%
OptionableYes Debt/Eq0.02 EPS Q/Q-11.20% Profit Margin- Rel Volume0.25 Prev Close1.38
ShortableYes LT Debt/Eq0.01 EarningsAug 08 AMC Payout- Avg Volume201.56K Price1.40
Recom1.25 SMA20-20.25% SMA50-37.72% SMA200-67.10% Volume50,916 Change1.45%
Date Action Analyst Rating Change Price Target Change
Nov-17-22Downgrade Stifel Buy → Hold $35 → $11
Jul-28-22Initiated H.C. Wainwright Buy $33
Sep-27-21Initiated Jefferies Buy $46
Sep-23-21Initiated Stifel Buy $32
Jul-13-21Initiated William Blair Outperform
May-04-21Resumed Piper Sandler Overweight $52
Dec-28-20Initiated Wedbush Outperform $48
Dec-28-20Initiated SVB Leerink Outperform $52
Dec-28-20Initiated Piper Sandler Overweight $60
Dec-28-20Initiated Goldman Buy $48
Sep-19-23 10:00AM
Sep-18-23 07:15PM
Aug-08-23 04:05PM
Jun-01-23 04:05PM
10:58AM Loading…
May-31-23 10:58AM
May-22-23 09:30AM
May-11-23 04:05PM
May-10-23 08:46AM
May-07-23 12:50PM
Apr-17-23 02:35PM
Mar-15-23 04:05PM
Mar-14-23 06:09PM
Feb-21-23 04:05PM
04:05PM Loading…
Feb-14-23 04:05PM
Feb-06-23 04:05PM
Jan-26-23 04:05PM
Jan-17-23 04:05PM
Jan-12-23 08:21AM
Nov-10-22 04:05PM
Oct-11-22 04:05PM
Oct-10-22 02:24PM
Sep-21-22 04:05PM
Sep-15-22 04:05PM
Aug-30-22 04:05PM
Aug-11-22 04:05PM
06:15AM Loading…
Aug-07-22 06:15AM
Aug-05-22 06:57AM
Aug-04-22 02:22PM
Aug-02-22 04:05PM
Jun-01-22 04:05PM
May-26-22 05:00PM
May-12-22 04:05PM
May-03-22 02:02PM
Apr-18-22 08:00AM
Apr-08-22 04:30PM
Mar-28-22 04:05PM
Mar-08-22 06:00PM
Mar-07-22 06:00AM
Feb-28-22 04:05PM
Feb-26-22 07:19AM
Feb-14-22 08:00AM
Feb-09-22 08:16AM
Feb-07-22 04:05PM
Jan-19-22 04:05PM
Jan-18-22 04:05PM
Jan-06-22 04:05PM
Dec-21-21 06:38PM
Dec-20-21 04:05PM
Dec-16-21 04:05PM
Nov-10-21 04:05PM
Nov-08-21 04:05PM
Nov-01-21 08:00AM
Oct-28-21 04:05PM
Oct-07-21 09:00AM
Sep-30-21 04:30PM
Sep-13-21 08:00AM
Aug-30-21 07:39AM
Aug-16-21 04:05PM
Aug-12-21 08:30AM
Jul-28-21 11:24AM
Jul-27-21 08:00AM
Jul-07-21 04:05PM
Jun-28-21 08:00AM
Jun-07-21 08:00AM
Jun-04-21 08:00AM
May-25-21 04:05PM
May-17-21 04:05PM
May-13-21 04:02PM
May-10-21 08:00AM
Apr-30-21 08:00AM
Mar-29-21 04:05PM
Mar-19-21 04:05PM
Mar-03-21 12:50AM
Feb-11-21 04:05PM
Dec-31-20 03:42PM
Dec-28-20 10:04AM
Dec-07-20 04:05PM
Dec-04-20 04:30PM
Dec-03-20 05:18PM
Dec-02-20 10:02PM
Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tananbaum James B.DirectorMay 08Buy2.801,780,0004,984,0003,525,957May 10 05:49 PM
Foresite Capital Management IV10% OwnerMay 08Buy2.801,780,0004,984,0003,525,957May 10 05:42 PM
GORDON CARL LDirectorMay 05Buy2.82981,0232,766,4851,368,339May 08 05:11 PM
ORBIMED ADVISORS LLCDirectorMay 05Buy2.82981,0232,766,4851,368,339May 08 05:22 PM
ORBIMED ADVISORS LLCDirectorMay 04Buy2.75479,9091,319,7504,738,453May 08 05:22 PM
GORDON CARL LDirectorMay 04Buy2.75479,9091,319,7504,738,453May 08 05:11 PM
ORBIMED ADVISORS LLCDirectorMay 02Buy2.67338,262903,1604,425,462May 02 09:34 PM
GORDON CARL LDirectorMay 02Buy2.67338,262903,1604,425,462May 02 09:38 PM
GORDON CARL LDirectorMay 01Buy2.62716,1571,876,3314,204,852May 02 09:38 PM
ORBIMED ADVISORS LLCDirectorMay 01Buy2.62716,1571,876,3314,204,852May 02 09:34 PM
ORBIMED ADVISORS LLCDirectorApr 28Buy2.55350,749894,4103,737,784May 02 09:34 PM
GORDON CARL LDirectorApr 28Buy2.55350,749894,4103,737,784May 02 09:38 PM